{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 3636, "items": [{"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T21:57:29Z", "timestamp": 1576792649346}, "reference-count": 21, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2011, 2, 1]]}, "DOI": "10.1200/jco.2010.32.5308", "type": "journal-article", "created": {"date-parts": [[2010, 12, 29]], "date-time": "2010-12-29T01:59:19Z", "timestamp": 1293587959000}, "page": "345-347", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Serum Prostate-Specific Antigen for the Early Detection of Prostate Cancer: Always, Never, or Only Sometimes?"], "prefix": "10.1200", "volume": "29", "author": [{"given": "Peter R.", "family": "Carroll", "sequence": "first", "affiliation": [{"name": "University of California at San Francisco, San Francisco, CA"}]}, {"given": "Jared M.", "family": "Whitson", "sequence": "additional", "affiliation": [{"name": "University of California at San Francisco, San Francisco, CA"}]}, {"given": "Matthew R.", "family": "Cooperberg", "sequence": "additional", "affiliation": [{"name": "University of California at San Francisco, San Francisco, CA"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.32.5308", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:31:12Z", "timestamp": 1574886672000}, "score": 83.920616, "issued": {"date-parts": [[2011, 2, 1]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[2011, 2, 1]]}, "issue": "4"}, "alternative-id": ["10.1200/JCO.2010.32.5308"], "URL": "http://dx.doi.org/10.1200/jco.2010.32.5308", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:51:47Z", "timestamp": 1574099507595}, "reference-count": 23, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 4, 1]], "date-time": "2001-04-01T00:00:00Z", "timestamp": 986083200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Urology"], "published-print": {"date-parts": [[2001, 4]]}, "DOI": "10.1016/s0090-4295(01)00913-x", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T17:00:41Z", "timestamp": 1027616441000}, "page": "591-593", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Serum prostate-specific antigen for prostate cancer early detection: total, free, age- stratified, or complexed?"], "prefix": "10.1016", "volume": "57", "author": [{"given": "Peter R", "family": "Carroll", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S009042950100913X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S009042950100913X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 25]], "date-time": "2019-04-25T11:26:35Z", "timestamp": 1556191595000}, "score": 62.037514, "issued": {"date-parts": [[2001, 4]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[2001, 4]]}, "issue": "4"}, "alternative-id": ["S009042950100913X"], "URL": "http://dx.doi.org/10.1016/s0090-4295(01)00913-x", "ISSN": ["0090-4295"], "issn-type": [{"value": "0090-4295", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:39:27Z", "timestamp": 1574113167988}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2001, 3, 1]], "date-time": "2001-03-01T00:00:00Z", "timestamp": 983404800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate Cancer Prostatic Dis"], "published-print": {"date-parts": [[2001, 3]]}, "DOI": "10.1038/sj.pcan.4500497", "type": "journal-article", "created": {"date-parts": [[2002, 9, 4]], "date-time": "2002-09-04T20:05:09Z", "timestamp": 1031169909000}, "page": "20-27", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Local therapy for prostate-specific antigen recurrence after definitive treatment"], "prefix": "10.1038", "volume": "4", "author": [{"given": "MV", "family": "Meng", "sequence": "first", "affiliation": []}, {"given": "PR", "family": "Carroll", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2001, 4, 20]]}, "container-title": ["Prostate Cancer and Prostatic Diseases"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/4500497.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4500497", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4500497.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T15:26:16Z", "timestamp": 1555341976000}, "score": 57.12891, "issued": {"date-parts": [[2001, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2001, 3]]}, "issue": "1"}, "alternative-id": ["BF4500497"], "URL": "http://dx.doi.org/10.1038/sj.pcan.4500497", "ISSN": ["1365-7852", "1476-5608"], "issn-type": [{"value": "1365-7852", "type": "print"}, {"value": "1476-5608", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:55:06Z", "timestamp": 1576799706368}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.14_suppl.4652", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T08:02:15Z", "timestamp": 1491379335000}, "page": "4652-4652", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Is prostate-specific antigen progression a surrogate for objective clinical progression in early prostate cancer?"], "prefix": "10.1200", "volume": "22", "author": [{"given": "D.", "family": "Newling", "sequence": "first", "affiliation": [{"name": "AstraZeneca, Macclesfield, United Kingdom"}]}, {"given": "K.", "family": "Carroll", "sequence": "additional", "affiliation": [{"name": "AstraZeneca, Macclesfield, United Kingdom"}]}, {"given": "T.", "family": "Morris", "sequence": "additional", "affiliation": [{"name": "AstraZeneca, Macclesfield, United Kingdom"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.14_suppl.4652", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:05:18Z", "timestamp": 1574892318000}, "score": 43.70368, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.14_suppl.4652"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.14_suppl.4652", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:56:11Z", "timestamp": 1576799771035}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.90140.4652", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T07:17:42Z", "timestamp": 1491376662000}, "page": "4652-4652", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Is prostate-specific antigen progression a surrogate for objective clinical progression in early prostate cancer?"], "prefix": "10.1200", "volume": "22", "author": [{"given": "D.", "family": "Newling", "sequence": "first", "affiliation": [{"name": "AstraZeneca, Macclesfield, United Kingdom"}]}, {"given": "K.", "family": "Carroll", "sequence": "additional", "affiliation": [{"name": "AstraZeneca, Macclesfield, United Kingdom"}]}, {"given": "T.", "family": "Morris", "sequence": "additional", "affiliation": [{"name": "AstraZeneca, Macclesfield, United Kingdom"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.4652", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:50:49Z", "timestamp": 1574891449000}, "score": 43.70368, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.90140.4652"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.90140.4652", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T05:41:59Z", "timestamp": 1574228519372}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Investigative Radiology"], "published-print": {"date-parts": [[1992, 9]]}, "DOI": "10.1097/00004424-199209000-00020", "type": "journal-article", "created": {"date-parts": [[2006, 9, 8]], "date-time": "2006-09-08T13:43:35Z", "timestamp": 1157723015000}, "page": "751", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Determination of Prostate Volume with Transrectal Ultrasound for Cancer Screening. Part I. Comparison with Prostate Specific Antigen Assays"], "prefix": "10.1097", "volume": "27", "author": [{"given": "Hedvig", "family": "Hricak", "sequence": "first", "affiliation": []}, {"given": "Peter", "family": "Carroll", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Investigative Radiology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T13:31:50Z", "timestamp": 1518183110000}, "score": 40.830338, "subtitle": [""], "issued": {"date-parts": [[1992, 9]]}, "references-count": 0, "journal-issue": {"issue": "9"}, "URL": "http://dx.doi.org/10.1097/00004424-199209000-00020", "ISSN": ["0020-9996"], "issn-type": [{"value": "0020-9996", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:37:01Z", "timestamp": 1575106621521}, "reference-count": 4, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 11, 1]], "date-time": "1996-11-01T00:00:00Z", "timestamp": 846806400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Journal of Urology"], "published-print": {"date-parts": [[1996, 11]]}, "DOI": "10.1097/00005392-199611000-00039", "type": "journal-article", "created": {"date-parts": [[2003, 11, 18]], "date-time": "2003-11-18T20:51:31Z", "timestamp": 1069188691000}, "page": "1685-1690", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Prospective Evaluation of Prostate Specific Antigen and Prostate Specific Antigen Density in the Detection of Nonpalpable and Stage T1C Carcinoma of the Prostate"], "prefix": "10.1097", "author": [{"given": "Joseph C.", "family": "Presti", "sequence": "first", "affiliation": []}, {"given": "Regina", "family": "Hovey", "sequence": "additional", "affiliation": []}, {"given": "Peter R.", "family": "Carroll", "sequence": "additional", "affiliation": []}, {"given": "Katsuto", "family": "Shinohara", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["The Journal of Urology"], "language": "en", "deposited": {"date-parts": [[2018, 12, 13]], "date-time": "2018-12-13T20:19:37Z", "timestamp": 1544732377000}, "score": 40.41075, "subtitle": [""], "issued": {"date-parts": [[1996, 11]]}, "references-count": 4, "URL": "http://dx.doi.org/10.1097/00005392-199611000-00039", "ISSN": ["0022-5347"], "issn-type": [{"value": "0022-5347", "type": "print"}], "subject": ["Urology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T16:17:06Z", "timestamp": 1575303426937}, "reference-count": 0, "publisher": "Harborside Press, LLC", "issue": "5S", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Natl Compr Canc Netw"], "published-print": {"date-parts": [[2018, 5]]}, "DOI": "10.6004/jnccn.2018.0036", "type": "journal-article", "created": {"date-parts": [[2018, 5, 21]], "date-time": "2018-05-21T13:55:15Z", "timestamp": 1526910915000}, "page": "620-623", "source": "Crossref", "is-referenced-by-count": 45, "title": ["NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection"], "prefix": "10.6004", "volume": "16", "author": [{"given": "Peter H.", "family": "Carroll", "sequence": "first", "affiliation": []}, {"given": "James L.", "family": "Mohler", "sequence": "additional", "affiliation": []}], "member": "4047", "published-online": {"date-parts": [[2018, 5, 21]]}, "container-title": ["Journal of the National Comprehensive Cancer Network"], "language": "en", "deposited": {"date-parts": [[2019, 3, 4]], "date-time": "2019-03-04T17:14:59Z", "timestamp": 1551719699000}, "score": 39.419827, "issued": {"date-parts": [[2018, 5]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2018, 5, 21]]}, "published-print": {"date-parts": [[2018, 5]]}, "issue": "5S"}, "alternative-id": ["10.6004/jnccn.2018.0036"], "URL": "http://dx.doi.org/10.6004/jnccn.2018.0036", "ISSN": ["1540-1405", "1540-1413"], "issn-type": [{"value": "1540-1405", "type": "print"}, {"value": "1540-1413", "type": "electronic"}], "subject": ["Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T21:25:24Z", "timestamp": 1574803524976}, "reference-count": 17, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 7, 1]], "date-time": "1994-07-01T00:00:00Z", "timestamp": 773020800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[1994, 7]]}, "DOI": "10.1016/s0022-5347(17)32832-x", "type": "journal-article", "created": {"date-parts": [[2017, 6, 30]], "date-time": "2017-06-30T12:11:37Z", "timestamp": 1498824697000}, "page": "120-123", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Comparison of Prostate Specific Antigen with Prostate Specific Antigen Density for 3 Clinical Applications"], "prefix": "10.1097", "volume": "152", "author": [{"given": "Katsuto", "family": "Shinohara", "sequence": "first", "affiliation": [{"name": "From the Department of Urology, University of California School of Medicine and Department of Veterans Affairs, San Francisco, California"}]}, {"given": "J. Stuart", "family": "Wolf", "sequence": "additional", "affiliation": [{"name": "From the Department of Urology, University of California School of Medicine and Department of Veterans Affairs, San Francisco, California"}]}, {"given": "Perinchery", "family": "Narayan", "sequence": "additional", "affiliation": [{"name": "From the Department of Urology, University of California School of Medicine and Department of Veterans Affairs, San Francisco, California"}]}, {"given": "Peter R.", "family": "Carroll", "sequence": "additional", "affiliation": [{"name": "From the Department of Urology, University of California School of Medicine and Department of Veterans Affairs, San Francisco, California"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S002253471732832X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S002253471732832X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T14:04:44Z", "timestamp": 1560780284000}, "score": 39.112766, "issued": {"date-parts": [[1994, 7]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[1994, 7]]}, "issue": "1"}, "alternative-id": ["10.1016/S0022-5347(17)32832-X"], "URL": "http://dx.doi.org/10.1016/s0022-5347(17)32832-x", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T07:11:23Z", "timestamp": 1574752283137}, "reference-count": 50, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Urology"], "published-print": {"date-parts": [[2017, 5]]}, "DOI": "10.1097/mou.0000000000000387", "type": "journal-article", "created": {"date-parts": [[2017, 2, 24]], "date-time": "2017-02-24T16:24:02Z", "timestamp": 1487953442000}, "page": "231-237", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Management of intermediate-risk prostate cancer with active surveillance"], "prefix": "10.1097", "volume": "27", "author": [{"given": "Selma", "family": "Masic", "sequence": "first", "affiliation": []}, {"suffix": "III", "given": "Samuel L.", "family": "Washington", "sequence": "additional", "affiliation": []}, {"given": "Peter R.", "family": "Carroll", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Current Opinion in Urology"], "language": "en", "link": [{"URL": "http://Insights.ovid.com/crossref?an=00042307-201705000-00008", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 19]], "date-time": "2019-09-19T02:49:51Z", "timestamp": 1568861391000}, "score": 39.04716, "subtitle": ["never or sometimes?"], "issued": {"date-parts": [[2017, 5]]}, "references-count": 50, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/mou.0000000000000387", "ISSN": ["0963-0643"], "issn-type": [{"value": "0963-0643", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:37:24Z", "timestamp": 1574177844238}, "reference-count": 10, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1997, 3, 1]], "date-time": "1997-03-01T00:00:00Z", "timestamp": 857174400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[1997, 3]]}, "DOI": "10.1016/s0022-5347(01)65080-8", "type": "journal-article", "created": {"date-parts": [[2006, 1, 17]], "date-time": "2006-01-17T21:48:07Z", "timestamp": 1137534487000}, "page": "907-912", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Prospective Evaluation of Prostate Specific Antigen and Prostate Specific Antigen Density in the Detection of Carcinoma of the Prostate: Ethnic Variations"], "prefix": "10.1097", "volume": "157", "author": [{"given": "Joseph C.", "family": "Presti", "sequence": "first", "affiliation": [{"name": "Departments of Urology and Pathology, University of California School of Medicine, San Francisco Veterans Administration Medical Center, and University of California-San Francisco/Mount Zion Cancer Center, San Francisco, California"}]}, {"given": "Regina", "family": "Hovey", "sequence": "additional", "affiliation": [{"name": "Departments of Urology and Pathology, University of California School of Medicine, San Francisco Veterans Administration Medical Center, and University of California-San Francisco/Mount Zion Cancer Center, San Francisco, California"}]}, {"given": "Vivek", "family": "Bhargava", "sequence": "additional", "affiliation": [{"name": "Departments of Urology and Pathology, University of California School of Medicine, San Francisco Veterans Administration Medical Center, and University of California-San Francisco/Mount Zion Cancer Center, San Francisco, California"}]}, {"given": "Peter R.", "family": "Carroll", "sequence": "additional", "affiliation": [{"name": "Departments of Urology and Pathology, University of California School of Medicine, San Francisco Veterans Administration Medical Center, and University of California-San Francisco/Mount Zion Cancer Center, San Francisco, California"}]}, {"given": "Katsuto", "family": "Shinohara", "sequence": "additional", "affiliation": [{"name": "Departments of Urology and Pathology, University of California School of Medicine, San Francisco Veterans Administration Medical Center, and University of California-San Francisco/Mount Zion Cancer Center, San Francisco, California"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0022534701650808?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0022534701650808?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T13:33:29Z", "timestamp": 1560778409000}, "score": 39.004856, "issued": {"date-parts": [[1997, 3]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[1997, 3]]}, "issue": "3"}, "alternative-id": ["10.1016/S0022-5347(01)65080-8"], "URL": "http://dx.doi.org/10.1016/s0022-5347(01)65080-8", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:36:57Z", "timestamp": 1574177817316}, "reference-count": 10, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 11, 1]], "date-time": "1996-11-01T00:00:00Z", "timestamp": 846806400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[1996, 11]]}, "DOI": "10.1016/s0022-5347(01)65483-1", "type": "journal-article", "created": {"date-parts": [[2006, 1, 17]], "date-time": "2006-01-17T21:48:07Z", "timestamp": 1137534487000}, "page": "1685-1690", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Prospective Evaluation of Prostate Specific Antigen and Prostate Specific Antigen Density in the Detection of Nonpalpable and Stage T1C Carcinoma of the Prostate"], "prefix": "10.1097", "volume": "156", "author": [{"given": "Joseph C. Jr.", "family": "Presti", "sequence": "first", "affiliation": [{"name": "Department of Urology, University of California School of Medicine, San Francisco Veterans Administration Medical Center and UCSF/Mt. Zion Cancer Center, San Francisco, California."}]}, {"given": "Regina", "family": "Hovey", "sequence": "additional", "affiliation": [{"name": "Department of Urology, University of California School of Medicine, San Francisco Veterans Administration Medical Center and UCSF/Mt. Zion Cancer Center, San Francisco, California."}]}, {"given": "Peter R.", "family": "Carroll", "sequence": "additional", "affiliation": [{"name": "Department of Urology, University of California School of Medicine, San Francisco Veterans Administration Medical Center and UCSF/Mt. Zion Cancer Center, San Francisco, California."}]}, {"given": "Katsuto", "family": "Shinohara", "sequence": "additional", "affiliation": [{"name": "Department of Urology, University of California School of Medicine, San Francisco Veterans Administration Medical Center and UCSF/Mt. Zion Cancer Center, San Francisco, California."}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0022534701654831?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0022534701654831?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T15:32:39Z", "timestamp": 1560785559000}, "score": 39.004856, "issued": {"date-parts": [[1996, 11]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[1996, 11]]}, "issue": "5"}, "alternative-id": ["10.1016/S0022-5347(01)65483-1"], "URL": "http://dx.doi.org/10.1016/s0022-5347(01)65483-1", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:37:09Z", "timestamp": 1575106629548}, "reference-count": 6, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1997, 3, 1]], "date-time": "1997-03-01T00:00:00Z", "timestamp": 857174400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Journal of Urology"], "published-print": {"date-parts": [[1997, 3]]}, "DOI": "10.1097/00005392-199703000-00045", "type": "journal-article", "created": {"date-parts": [[2003, 11, 18]], "date-time": "2003-11-18T20:58:22Z", "timestamp": 1069189102000}, "page": "907-911", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Prospective Evaluation of Prostate Specific Antigen and Prostate Specific Antigen Density in the Detection of Carcinoma of the Prostate"], "prefix": "10.1097", "author": [{"given": "Joseph C.", "family": "Presti", "sequence": "first", "affiliation": []}, {"given": "Regina", "family": "Hovey", "sequence": "additional", "affiliation": []}, {"given": "Vivek", "family": "Bhargava", "sequence": "additional", "affiliation": []}, {"given": "Peter R.", "family": "Carroll", "sequence": "additional", "affiliation": []}, {"given": "Katsuto", "family": "Shinohara", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["The Journal of Urology"], "language": "en", "deposited": {"date-parts": [[2018, 12, 13]], "date-time": "2018-12-13T20:21:14Z", "timestamp": 1544732474000}, "score": 39.004856, "subtitle": ["Ethnic Variations"], "issued": {"date-parts": [[1997, 3]]}, "references-count": 6, "URL": "http://dx.doi.org/10.1097/00005392-199703000-00045", "ISSN": ["0022-5347"], "issn-type": [{"value": "0022-5347", "type": "print"}], "subject": ["Urology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T00:02:28Z", "timestamp": 1574121748590}, "reference-count": 18, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1993, 8, 1]], "date-time": "1993-08-01T00:00:00Z", "timestamp": 744163200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Urology"], "published-print": {"date-parts": [[1993, 8]]}, "DOI": "10.1016/0090-4295(93)90635-n", "type": "journal-article", "created": {"date-parts": [[2004, 4, 21]], "date-time": "2004-04-21T01:22:48Z", "timestamp": 1082510568000}, "page": "130-137", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Combined role of transrectal ultrasonography, gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer"], "prefix": "10.1016", "volume": "42", "author": [{"suffix": "Jr.", "given": "J.Stuart", "family": "Wolf", "sequence": "first", "affiliation": []}, {"given": "Katsuto", "family": "Shinohara", "sequence": "additional", "affiliation": []}, {"given": "Peter R.", "family": "Carroll", "sequence": "additional", "affiliation": []}, {"given": "Perinchery", "family": "Narayan", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:009042959390635N?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:009042959390635N?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 10]], "date-time": "2019-02-10T18:57:20Z", "timestamp": 1549825040000}, "score": 38.120193, "issued": {"date-parts": [[1993, 8]]}, "references-count": 18, "journal-issue": {"published-print": {"date-parts": [[1993, 8]]}, "issue": "2"}, "alternative-id": ["009042959390635N"], "URL": "http://dx.doi.org/10.1016/0090-4295(93)90635-n", "ISSN": ["0090-4295"], "issn-type": [{"value": "0090-4295", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T20:44:13Z", "timestamp": 1575060253904}, "reference-count": 59, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 2, 1]], "date-time": "2001-02-01T00:00:00Z", "timestamp": 980985600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Urology"], "published-print": {"date-parts": [[2001, 2]]}, "DOI": "10.1016/s0090-4295(00)00993-6", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T11:33:42Z", "timestamp": 1027596822000}, "page": "217-224", "source": "Crossref", "is-referenced-by-count": 50, "title": ["Prostate-specific antigen best practice policy\u2014part I: early detection and diagnosis of prostate cancer"], "prefix": "10.1016", "volume": "57", "author": [{"given": "Peter", "family": "Carroll", "sequence": "first", "affiliation": []}, {"given": "Christopher", "family": "Coley", "sequence": "additional", "affiliation": []}, {"given": "David", "family": "McLeod", "sequence": "additional", "affiliation": []}, {"given": "Paul", "family": "Schellhammer", "sequence": "additional", "affiliation": []}, {"given": "Greg", "family": "Sweat", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Wasson", "sequence": "additional", "affiliation": []}, {"given": "Anthony", "family": "Zietman", "sequence": "additional", "affiliation": []}, {"given": "Ian", "family": "Thompson", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0090429500009936?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0090429500009936?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 1]], "date-time": "2019-05-01T17:57:50Z", "timestamp": 1556733470000}, "score": 38.07189, "issued": {"date-parts": [[2001, 2]]}, "references-count": 59, "journal-issue": {"published-print": {"date-parts": [[2001, 2]]}, "issue": "2"}, "alternative-id": ["S0090429500009936"], "URL": "http://dx.doi.org/10.1016/s0090-4295(00)00993-6", "ISSN": ["0090-4295"], "issn-type": [{"value": "0090-4295", "type": "print"}], "subject": ["Urology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:47:06Z", "timestamp": 1574282826814}, "reference-count": 0, "publisher": "Medknow", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Postgrad Med"], "published-print": {"date-parts": [[2009]]}, "DOI": "10.4103/0022-3859.43548", "type": "journal-article", "created": {"date-parts": [[2009, 2, 27]], "date-time": "2009-02-27T04:35:16Z", "timestamp": 1235709316000}, "page": "17", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Detection rate of prostate cancer using prostate specific antigen in patients presenting with lower urinary tract symptoms: A retrospective study"], "prefix": "10.4103", "volume": "55", "author": [{"given": "PR", "family": "Chavan", "sequence": "first", "affiliation": []}, {"given": "SV", "family": "Chavan", "sequence": "additional", "affiliation": []}, {"given": "NR", "family": "Chavan", "sequence": "additional", "affiliation": []}, {"given": "VD", "family": "Trivedi", "sequence": "additional", "affiliation": []}], "member": "2581", "container-title": ["Journal of Postgraduate Medicine"], "language": "en", "deposited": {"date-parts": [[2009, 5, 15]], "date-time": "2009-05-15T09:16:00Z", "timestamp": 1242378960000}, "score": 37.838646, "issued": {"date-parts": [[2009]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2009]]}, "issue": "1"}, "alternative-id": ["43548"], "URL": "http://dx.doi.org/10.4103/0022-3859.43548", "ISSN": ["0022-3859"], "issn-type": [{"value": "0022-3859", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T05:09:59Z", "timestamp": 1574312999111}, "reference-count": 20, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 7, 1]], "date-time": "2007-07-01T00:00:00Z", "timestamp": 1183248000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Urology"], "published-print": {"date-parts": [[2007, 7]]}, "DOI": "10.1016/j.urology.2007.03.018", "type": "journal-article", "created": {"date-parts": [[2007, 7, 25]], "date-time": "2007-07-25T11:18:23Z", "timestamp": 1185362303000}, "page": "106-110", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Adjuvant Radiotherapy in Prostate Cancer: Predictors of Prostate-Specific Antigen Recurrence from the CaPSURE Database"], "prefix": "10.1016", "volume": "70", "author": [{"given": "O. Kenneth", "family": "Macdonald", "sequence": "first", "affiliation": []}, {"given": "Anthony V.", "family": "D\u2019Amico", "sequence": "additional", "affiliation": []}, {"given": "Natalia", "family": "Sadetsky", "sequence": "additional", "affiliation": []}, {"given": "Dennis C.", "family": "Shrieve", "sequence": "additional", "affiliation": []}, {"given": "Peter R.", "family": "Carroll", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0090429507003718?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0090429507003718?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 1]], "date-time": "2019-05-01T12:46:19Z", "timestamp": 1556714779000}, "score": 36.7143, "issued": {"date-parts": [[2007, 7]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2007, 7]]}, "issue": "1"}, "alternative-id": ["S0090429507003718"], "URL": "http://dx.doi.org/10.1016/j.urology.2007.03.018", "ISSN": ["0090-4295"], "issn-type": [{"value": "0090-4295", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:55:02Z", "timestamp": 1576799702617}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.14_suppl.4551", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T08:02:15Z", "timestamp": 1491379335000}, "page": "4551-4551", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Is prostate-specific antigen a surrogate for survival in advanced prostate cancer?"], "prefix": "10.1200", "volume": "22", "author": [{"given": "L.", "family": "Collette", "sequence": "first", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "T.", "family": "Burzykowski", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "K.", "family": "Carroll", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "D.", "family": "Newling", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "T.", "family": "Morris", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "F.", "family": "Schroder", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.14_suppl.4551", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:05:26Z", "timestamp": 1574892326000}, "score": 36.7143, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.14_suppl.4551"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.14_suppl.4551", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:56:07Z", "timestamp": 1576799767443}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.90140.4551", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T07:17:42Z", "timestamp": 1491376662000}, "page": "4551-4551", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Is prostate-specific antigen a surrogate for survival in advanced prostate cancer?"], "prefix": "10.1200", "volume": "22", "author": [{"given": "L.", "family": "Collette", "sequence": "first", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "T.", "family": "Burzykowski", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "K.", "family": "Carroll", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "D.", "family": "Newling", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "T.", "family": "Morris", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}, {"given": "F.", "family": "Schroder", "sequence": "additional", "affiliation": [{"name": "EORTC Data Center, Brussels, Belgium; Limburgs Universitair Centrum, Diepenbeek, Belgium; AstraZeneca, Macclesfield, United Kingdom; Erasmus Medical Centrum, Rotterdam, Netherlands"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.4551", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:50:43Z", "timestamp": 1574891443000}, "score": 36.7143, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.90140.4551"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.90140.4551", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:23:43Z", "timestamp": 1574519023822}, "publisher-location": "Totowa, NJ", "reference-count": 115, "publisher": "Humana Press", "isbn-type": [{"value": "9781627031813", "type": "print"}, {"value": "9781627031820", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1007/978-1-62703-182-0_2", "type": "book-chapter", "created": {"date-parts": [[2012, 11, 30]], "date-time": "2012-11-30T22:05:03Z", "timestamp": 1354313103000}, "page": "17-36", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Changing Landscape of Prostate Cancer Favoring Low-Risk Prostate Cancer: Implications for Active Surveillance Versus Focal Therapy"], "prefix": "10.1007", "author": [{"given": "Byron H.", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "Peter R.", "family": "Carroll", "sequence": "additional", "affiliation": []}, {"given": "Eric A.", "family": "Klein", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 11, 3]]}, "reference": [{"key": "2_CR00021", "author": "JL Stanford", "year": "1999", "unstructured": "Stanford JL, Stephenson RA, Coyle LM, et al. Prostate Cancer Trends 1973\u20131995. Bethesda, MD: National Cancer Institute; 1999.", "volume-title": "Prostate Cancer Trends 1973\u20131995"}, {"key": "2_CR00022", "unstructured": "Altekruse S, Kosary C, Krapcho M, et al. SEER cancer statistics review, 1975\u20132007. Based on November 2009 SEER data submission, posted to the SEER web site. \n                    http://seer.cancer.gov/csr/1975_2007/\n                    \n                  ."}, {"issue": "13", "key": "2_CR00023", "doi-asserted-by": "crossref", "first-page": "981", "DOI": "10.1093/jnci/94.13.981", "volume": "94", "author": "R Etzioni", "year": "2002", "unstructured": "Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981\u201390.", "journal-title": "J Natl Cancer Inst"}, {"issue": "8", "key": "2_CR00024", "doi-asserted-by": "crossref", "first-page": "948", "DOI": "10.1001/jama.1993.03510080052031", "volume": "270", "author": "WJ Catalona", "year": "1993", "unstructured": "Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA. 1993;270(8):948\u201354.", "journal-title": "JAMA"}, {"issue": "5", "key": "2_CR00025", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1016/S0025-6196(11)63720-8", "volume": "73", "author": "CL Amling", "year": "1998", "unstructured": "Amling CL, Blute ML, Lerner SE, Bergstralh EJ, Bostwick DG, Zincke H. Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice. Mayo Clin Proc. 1998;73(5):401\u20136.", "journal-title": "Mayo Clin Proc"}, {"issue": "18", "key": "2_CR00026", "doi-asserted-by": "crossref", "first-page": "1445", "DOI": "10.1001/jama.1997.03540420041027", "volume": "277", "author": "AW Partin", "year": "1997", "unstructured": "Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997;277(18):1445\u201351.", "journal-title": "JAMA"}, {"issue": "12", "key": "2_CR00027", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1093/jnci/91.12.1017", "volume": "91", "author": "BF Hankey", "year": "1999", "unstructured": "Hankey BF, Feuer EJ, Clegg LX, et al. Cancer surveillance series: interpreting trends in prostate cancer\u2013part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst. 1999;91(12):1017\u201324.", "journal-title": "J Natl Cancer Inst"}, {"issue": "10", "key": "2_CR00028", "doi-asserted-by": "crossref", "first-page": "3167", "DOI": "10.1200/JCO.1999.17.10.3167", "volume": "17", "author": "FM Jhaveri", "year": "1999", "unstructured": "Jhaveri FM, Klein EA, Kupelian PA, Zippe C, Levin HS. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. J Clin Oncol. 1999;17(10): 3167\u201372.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "2_CR00029", "doi-asserted-by": "crossref", "first-page": "1283", "DOI": "10.1016/S0022-5347(17)35233-3", "volume": "151", "author": "WJ Catalona", "year": "1994", "unstructured": "Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994;151(5):1283\u201390.", "journal-title": "J Urol"}, {"issue": "22", "key": "2_CR000210", "doi-asserted-by": "crossref", "first-page": "2239", "DOI": "10.1056/NEJMoa031918", "volume": "350", "author": "IM Thompson", "year": "2004", "unstructured": "Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level \u2009< \u2009or =4.0 ng per milliliter. N Engl J Med. 2004;350(22):2239\u201346.", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "2_CR000211", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1016/j.eururo.2007.09.002", "volume": "53", "author": "A Heidenreich", "year": "2008", "unstructured": "Heidenreich A, Aus G, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol. 2008;53(1):68\u201380.", "journal-title": "Eur Urol"}, {"issue": "2", "key": "2_CR000212", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.6004/jnccn.2010.0016", "volume": "8", "author": "MH Kawachi", "year": "2010", "unstructured": "Kawachi MH, Bahnson RR, Barry M, et al. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010; 8(2):240\u201362.", "journal-title": "J Natl Compr Canc Netw"}, {"issue": "1", "key": "2_CR000213", "doi-asserted-by": "crossref", "first-page": "152", "DOI": "10.1016/S0022-5347(05)67993-1", "volume": "163", "author": "RJ Babaian", "year": "2000", "unstructured": "Babaian RJ, Toi A, Kamoi K, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol. 2000;163(1):152\u20137.", "journal-title": "J Urol"}, {"issue": "6", "key": "2_CR000214", "doi-asserted-by": "crossref", "first-page": "1571", "DOI": "10.1016/S0022-5347(17)35304-1", "volume": "151", "author": "DW Keetch", "year": "1994", "unstructured": "Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol. 1994;151(6): 1571\u20134.", "journal-title": "J Urol"}, {"issue": "4", "key": "2_CR000215", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1159/000283071", "volume": "59", "author": "MK Terris", "year": "1997", "unstructured": "Terris MK, Wallen EM, Stamey TA. Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int. 1997;59(4): 239\u201342.", "journal-title": "Urol Int"}, {"issue": "11", "key": "2_CR000216", "doi-asserted-by": "crossref", "first-page": "2141", "DOI": "10.1200/JCO.2004.10.062", "volume": "22", "author": "MR Cooperberg", "year": "2004", "unstructured": "Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 2004;22(11):2141\u20139.", "journal-title": "J Clin Oncol"}, {"issue": "11", "key": "2_CR000217", "doi-asserted-by": "crossref", "first-page": "969", "DOI": "10.1001/jama.280.11.969", "volume": "280", "author": "AV D'Amico", "year": "1998", "unstructured": "D\u2019Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969\u201374.", "journal-title": "JAMA"}, {"issue": "2", "key": "2_CR000218", "doi-asserted-by": "crossref", "first-page": "416", "DOI": "10.1016/S0022-5347(05)65955-1", "volume": "166", "author": "M Han", "year": "2001", "unstructured": "Han M, Partin AW, Piantadosi S, Epstein JI, Walsh PC. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol. 2001;166(2):416\u20139.", "journal-title": "J Urol"}, {"issue": "26", "key": "2_CR000219", "doi-asserted-by": "crossref", "first-page": "4300", "DOI": "10.1200/JCO.2008.18.2501", "volume": "27", "author": "AJ Stephenson", "year": "2009", "unstructured": "Stephenson AJ, Kattan MW, Eastham JA, et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol. 2009;27(26):4300\u20135.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "2_CR000220", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1016/S0360-3016(02)02940-1", "volume": "54", "author": "AV D'Amico", "year": "2002", "unstructured": "D\u2019Amico AV, Chen MH, Oh-Ung J, et al. Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era. Int J Radiat Oncol Biol Phys. 2002;54(2):436\u201341.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "17", "key": "2_CR000221", "doi-asserted-by": "crossref", "first-page": "1248", "DOI": "10.1093/jnci/dji248", "volume": "97", "author": "PC Albertsen", "year": "2005", "unstructured": "Albertsen PC, Hanley JA, Barrows GH, et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst. 2005;97(17):1248\u201353.", "journal-title": "J Natl Cancer Inst"}, {"issue": "17", "key": "2_CR000222", "doi-asserted-by": "crossref", "first-page": "2095", "DOI": "10.1001/jama.293.17.2095", "volume": "293", "author": "PC Albertsen", "year": "2005", "unstructured": "Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293(17): 2095\u2013101.", "journal-title": "JAMA"}, {"issue": "13", "key": "2_CR000223", "doi-asserted-by": "crossref", "first-page": "1310", "DOI": "10.1056/NEJMoa0810696", "volume": "360", "author": "GL Andriole", "year": "2009", "unstructured": "Andriole GL, Crawford ED, Grubb 3rd RL, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310\u20139.", "journal-title": "N Engl J Med"}, {"issue": "13", "key": "2_CR000224", "doi-asserted-by": "crossref", "first-page": "1320", "DOI": "10.1056/NEJMoa0810084", "volume": "360", "author": "FH Schroder", "year": "2009", "unstructured": "Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360(13):1320\u20138.", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "2_CR000225", "doi-asserted-by": "crossref", "first-page": "374", "DOI": "10.1093/jnci/djp001", "volume": "101", "author": "G Draisma", "year": "2009", "unstructured": "Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst. 2009;101(6):374\u201383.", "journal-title": "J Natl Cancer Inst"}, {"issue": "14", "key": "2_CR000226", "first-page": "1256", "volume": "170", "author": "YH Shao", "year": "2010", "unstructured": "Shao YH, Albertsen PC, Roberts CB, et al. Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml. Arch Intern Med. 2010; 170(14):1256\u201361.", "journal-title": "Arch Intern Med"}, {"issue": "2", "key": "2_CR000227", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/S1470-2045(04)01384-1", "volume": "5", "author": "C Parker", "year": "2004", "unstructured": "Parker C. Active surveillance: towards a new paradigm in the management of early prostate cancer. Lancet Oncol. 2004;5(2):101\u20136.", "journal-title": "Lancet Oncol"}, {"issue": "2", "key": "2_CR000228", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1200/JCO.2002.20.2.557", "volume": "20", "author": "JT Wei", "year": "2002", "unstructured": "Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002;20(2):557\u201366.", "journal-title": "J Clin Oncol"}, {"issue": "3 Suppl", "key": "2_CR000229", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L", "volume": "71", "author": "TA Stamey", "year": "1993", "unstructured": "Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer. 1993;71(3 Suppl):933\u20138.", "journal-title": "Cancer"}, {"issue": "5", "key": "2_CR000230", "doi-asserted-by": "crossref", "first-page": "368", "DOI": "10.1001/jama.1994.03510290050036", "volume": "271", "author": "JI Epstein", "year": "1994", "unstructured": "Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271(5):368\u201374.", "journal-title": "JAMA"}, {"issue": "4", "key": "2_CR000231", "doi-asserted-by": "crossref", "first-page": "1330", "DOI": "10.1016/j.juro.2008.06.019", "volume": "180", "author": "DA Barocas", "year": "2008", "unstructured": "Barocas DA, Cowan JE, Smith Jr JA, Carroll PR. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol. 2008;180(4):1330\u20134 (discussion 1334\u20131335).", "journal-title": "J Urol"}, {"issue": "5", "key": "2_CR000232", "doi-asserted-by": "crossref", "first-page": "1792", "DOI": "10.1097/01.ju.0000091806.70171.41", "volume": "170", "author": "MW Kattan", "year": "2003", "unstructured": "Kattan MW, Eastham JA, Wheeler TM, et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol. 2003;170(5): 1792\u20137.", "journal-title": "J Urol"}, {"issue": "10", "key": "2_CR000233", "doi-asserted-by": "crossref", "first-page": "2218", "DOI": "10.1002/cncr.23029", "volume": "110", "author": "S Roemeling", "year": "2007", "unstructured": "Roemeling S, Roobol MJ, Kattan MW, van der Kwast TH, Steyerberg EW, Schroder FH. Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations. Cancer. 2007;110(10): 2218\u201321.", "journal-title": "Cancer"}, {"issue": "1", "key": "2_CR000234", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1016/j.eururo.2009.10.025", "volume": "58", "author": "MC Lee", "year": "2010", "unstructured": "Lee MC, Dong F, Stephenson AJ, Jones JS, Magi-Galluzzi C, Klein EA. The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy. Eur Urol. 2010;58(1):90\u20135.", "journal-title": "Eur Urol"}, {"issue": "4", "key": "2_CR000235", "doi-asserted-by": "crossref", "first-page": "1628", "DOI": "10.1016/j.juro.2008.11.107", "volume": "181", "author": "SL Conti", "year": "2009", "unstructured": "Conti SL, Dall\u2019era M, Fradet V, Cowan JE, Simko J, Carroll PR. Pathological outcomes of candidates for active surveillance of prostate cancer. J Urol. 2009;181(4):1628\u201333 (discussion 1633\u20131624).", "journal-title": "J Urol"}, {"issue": "32", "key": "2_CR000236", "doi-asserted-by": "crossref", "first-page": "8165", "DOI": "10.1200/JCO.2005.03.3134", "volume": "23", "author": "L Klotz", "year": "2005", "unstructured": "Klotz L. Active surveillance for prostate cancer: for whom? J Clin Oncol. 2005;23(32):8165\u20139.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "2_CR000237", "doi-asserted-by": "crossref", "first-page": "1244", "DOI": "10.1016/j.eururo.2006.11.053", "volume": "51", "author": "S Roemeling", "year": "2007", "unstructured": "Roemeling S, Roobol MJ, de Vries SH, et al. Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome. Eur Urol. 2007;51(5):1244\u201350 (discussion 1251).", "journal-title": "Eur Urol"}, {"issue": "2", "key": "2_CR000238", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1200/JCO.2010.31.4252", "volume": "29", "author": "MR Cooperberg", "year": "2011", "unstructured": "Cooperberg MR, Cowan JE, Hilton JF, et al. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol. 2011;29(2):228\u201334.", "journal-title": "J Clin Oncol"}, {"issue": "6", "key": "2_CR000239", "doi-asserted-by": "crossref", "first-page": "1095", "DOI": "10.1016/j.urology.2007.03.042", "volume": "69", "author": "DV Makarov", "year": "2007", "unstructured": "Makarov DV, Trock BJ, Humphreys EB, et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology. 2007;69(6): 1095\u2013101.", "journal-title": "Urology"}, {"issue": "6", "key": "2_CR000240", "doi-asserted-by": "crossref", "first-page": "2359", "DOI": "10.1016/j.juro.2007.08.039", "volume": "178", "author": "HB Carter", "year": "2007", "unstructured": "Carter HB, Kettermann A, Warlick C, et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol. 2007;178(6):2359\u201364 (discussion 2364\u20132355).", "journal-title": "J Urol"}, {"issue": "4", "key": "2_CR000241", "doi-asserted-by": "crossref", "first-page": "1635", "DOI": "10.1016/j.juro.2008.11.109", "volume": "181", "author": "SE Eggener", "year": "2009", "unstructured": "Eggener SE, Mueller A, Berglund RK, et al. A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol. 2009;181(4):1635\u201341 (discussion 1641).", "journal-title": "J Urol"}, {"issue": "1", "key": "2_CR000242", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1200/JCO.2009.24.2180", "volume": "28", "author": "L Klotz", "year": "2010", "unstructured": "Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1):126\u201331.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "2_CR000243", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1056/NEJMoa032975", "volume": "351", "author": "AV D'Amico", "year": "2004", "unstructured": "D\u2019Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004;351(2):125\u201335.", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "2_CR000244", "doi-asserted-by": "crossref", "first-page": "440", "DOI": "10.1001/jama.294.4.440", "volume": "294", "author": "AV D'Amico", "year": "2005", "unstructured": "D\u2019Amico AV, Renshaw AA, Sussman B, Chen MH. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA. 2005;294(4):440\u20137.", "journal-title": "JAMA"}, {"issue": "21", "key": "2_CR000245", "doi-asserted-by": "crossref", "first-page": "1521", "DOI": "10.1093/jnci/djj410", "volume": "98", "author": "HB Carter", "year": "2006", "unstructured": "Carter HB, Ferrucci L, Kettermann A, et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst. 2006;98(21):1521\u20137.", "journal-title": "J Natl Cancer Inst"}, {"issue": "12", "key": "2_CR000246", "doi-asserted-by": "crossref", "first-page": "2664", "DOI": "10.1002/cncr.23502", "volume": "112", "author": "MA Dall\u2019Era", "year": "2008", "unstructured": "Dall\u2019Era MA, Konety BR, Cowan JE, et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer. 2008;112(12): 2664\u201370.", "journal-title": "Cancer"}, {"issue": "1", "key": "2_CR000247", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1016/j.urology.2010.04.068", "volume": "77", "author": "S Loeb", "year": "2011", "unstructured": "Loeb S, Carter HB, Schaeffer EM, Kettermann A, Ferrucci L, Metter EJ. Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal study of aging. Urology. 2011;77(1):143\u20137.", "journal-title": "Urology"}, {"issue": "5", "key": "2_CR000248", "doi-asserted-by": "crossref", "first-page": "978", "DOI": "10.1016/j.eururo.2008.07.069", "volume": "54", "author": "S Loeb", "year": "2008", "unstructured": "Loeb S, Kettermann A, Ferrucci L, Landis P, Metter EJ, Carter BH. The optimal application of prostate-specific antigen (PSA) velocity to predict high-risk disease. Eur Urol. 2008;54(5):978\u20139.", "journal-title": "Eur Urol"}, {"issue": "5", "key": "2_CR000249", "doi-asserted-by": "crossref", "first-page": "1073", "DOI": "10.1016/j.eururo.2008.06.076", "volume": "54", "author": "S Loeb", "year": "2008", "unstructured": "Loeb S, Kettermann A, Ferrucci L, Landis P, Metter EJ, Carter HB. PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal study of aging. Eur Urol. 2008;54(5):1073\u201380.", "journal-title": "Eur Urol"}, {"issue": "17", "key": "2_CR000250", "doi-asserted-by": "crossref", "first-page": "2810", "DOI": "10.1200/JCO.2009.25.7311", "volume": "28", "author": "AE Ross", "year": "2010", "unstructured": "Ross AE, Loeb S, Landis P, et al. Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program. J Clin Oncol. 2010;28(17):2810\u20136.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "2_CR000251", "doi-asserted-by": "crossref", "first-page": "1964", "DOI": "10.1016/j.juro.2008.07.051", "volume": "180", "author": "RK Berglund", "year": "2008", "unstructured": "Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol. 2008;180(5):1964\u20137 (discussion 1967\u20131968).", "journal-title": "J Urol"}, {"issue": "5", "key": "2_CR000252", "doi-asserted-by": "crossref", "first-page": "1688", "DOI": "10.1016/S0022-5347(05)65654-6", "volume": "166", "author": "JI Epstein", "year": "2001", "unstructured": "Epstein JI, Walsh PC, Carter HB. Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease. J Urol. 2001; 166(5):1688\u201391.", "journal-title": "J Urol"}, {"issue": "1", "key": "2_CR000253", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1002/ijc.22161", "volume": "120", "author": "A Khatami", "year": "2007", "unstructured": "Khatami A, Aus G, Damber JE, Lilja H, Lodding P, Hugosson J. PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden section. Int J Cancer. 2007;120(1):170\u20134.", "journal-title": "Int J Cancer"}, {"issue": "5", "key": "2_CR000254", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1097/PPO.0b013e318156ff65", "volume": "13", "author": "NJ As van", "year": "2007", "unstructured": "van As NJ, Parker CC. Active surveillance with selective radical treatment for localized prostate cancer. Cancer J. 2007;13(5):289\u201394.", "journal-title": "Cancer J"}, {"issue": "1", "key": "2_CR000255", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.eururo.2008.09.007", "volume": "55", "author": "RC Bergh van den", "year": "2009", "unstructured": "van den Bergh RC, Roemeling S, Roobol MJ, et al. Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol. 2009;55(1):1\u20138.", "journal-title": "Eur Urol"}, {"issue": "28", "key": "2_CR000256", "doi-asserted-by": "crossref", "first-page": "7005", "DOI": "10.1200/JCO.2005.01.867", "volume": "23", "author": "AJ Stephenson", "year": "2005", "unstructured": "Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005;23(28): 7005\u201312.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "2_CR000257", "doi-asserted-by": "crossref", "first-page": "2274", "DOI": "10.1016/j.juro.2009.07.024", "volume": "182", "author": "AS Duffield", "year": "2009", "unstructured": "Duffield AS, Lee TK, Miyamoto H, Carter HB, Epstein JI. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. J Urol. 2009;182(5):2274\u20138.", "journal-title": "J Urol"}, {"key": "2_CR000258", "unstructured": "van den Bergh RC, Steyerberg EW, Khatami A, et al. Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer. Mar 1;116(5):1281-1290.", "DOI": "10.1002/cncr.24882", "doi-asserted-by": "crossref"}, {"key": "2_CR000259", "unstructured": "Dall\u2019era MA, Cowan JE, Simko J, et al. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. Aug 26 2010.", "DOI": "10.1111/j.1464-410X.2010.09589.x", "doi-asserted-by": "crossref"}, {"key": "2_CR000260", "unstructured": "Hayes JH, Ollendorf DA, Pearson SD, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. Dec 1;304(21):2373-2380.", "DOI": "10.1001/jama.2010.1720", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "2_CR000261", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1038/ncpuro0124", "volume": "2", "author": "L. Klotz", "year": "2005", "unstructured": "Klotz L. Active surveillance with selective delayed intervention is the way to manage \u2018good-risk\u2019 prostate cancer. Nat Clin Pract Urol. Mar 2005;2(3):136-142; quiz 131 p following 149.", "journal-title": "Nat Clin Pract Urol. Mar"}, {"issue": "2", "key": "2_CR000262", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/j.juro.2006.03.030", "volume": "176", "author": "RM Martin", "year": "2006", "unstructured": "Martin RM, Gunnell D, Hamdy F, Neal D, Lane A, Donovan J. Continuing controversy over monitoring men with localized prostate cancer: a systematic review of programs in the prostate specific antigen era. J Urol. 2006;176(2):439\u201349.", "journal-title": "J Urol"}, {"issue": "3 Pt 1", "key": "2_CR000263", "doi-asserted-by": "crossref", "first-page": "826", "DOI": "10.1016/j.juro.2007.05.039", "volume": "178", "author": "DM Latini", "year": "2007", "unstructured": "Latini DM, Hart SL, Knight SJ, et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol. Sep 2007;178(3 Pt 1):826-831; discussion 831-822.", "journal-title": "J Urol. Sep"}, {"issue": "1", "key": "2_CR000264", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1002/cncr.10651", "volume": "95", "author": "MS Litwin", "year": "2002", "unstructured": "Litwin MS, Lubeck DP, Spitalny GM, Henning JM, Carroll PR. Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. Cancer. 2002;95(1):54\u201360.", "journal-title": "Cancer"}, {"issue": "5", "key": "2_CR000265", "doi-asserted-by": "crossref", "first-page": "1786", "DOI": "10.1016/j.juro.2009.12.099", "volume": "183", "author": "RC Bergh van den", "year": "2010", "unstructured": "van den Bergh RC, Essink-Bot ML, Roobol MJ, Schroder FH, Bangma CH, Steyerberg EW. Do anxiety and distress increase during active surveillance for low risk prostate cancer? J Urol. 2010;183(5): 1786\u201391.", "journal-title": "J Urol"}, {"issue": "6 Suppl", "key": "2_CR000266", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/j.urology.2007.06.1129", "volume": "70", "author": "I Meiers", "year": "2007", "unstructured": "Meiers I, Waters DJ, Bostwick DG. Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007. Urology. 2007;70(6 Suppl):3\u20138.", "journal-title": "Urology"}, {"issue": "2", "key": "2_CR000267", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1016/S0090-4295(02)01728-4", "volume": "60", "author": "AM Wise", "year": "2002", "unstructured": "Wise AM, Stamey TA, McNeal JE, Clayton JL. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology. 2002;60(2):264\u20139.", "journal-title": "Urology"}, {"issue": "2 Pt 1", "key": "2_CR000268", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1097/01.ju.0000070928.49986.04", "volume": "170", "author": "M Noguchi", "year": "2003", "unstructured": "Noguchi M, Stamey TA, McNeal JE, Nolley R. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol. 2003;170 (2 Pt 1):459\u201363.", "journal-title": "J Urol"}, {"issue": "11", "key": "2_CR000269", "doi-asserted-by": "crossref", "first-page": "1607", "DOI": "10.1111/j.1464-410X.2010.09436.x", "volume": "106", "author": "SR Bott", "year": "2010", "unstructured": "Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int. 2010;106(11): 1607\u201311.", "journal-title": "BJU Int"}, {"issue": "Suppl 4", "key": "2_CR000270", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1159/000052577", "volume": "39", "author": "TA Stamey", "year": "2001", "unstructured": "Stamey TA, McNeal JM, Wise AM, Clayton JL. Secondary cancers in the prostate do not determine PSA biochemical failure in untreated men undergoing radical retropubic prostatectomy. Eur Urol. 2001;39 Suppl 4:22\u20133.", "journal-title": "Eur Urol"}, {"issue": "5", "key": "2_CR000271", "doi-asserted-by": "crossref", "first-page": "559", "DOI": "10.1038/nm.1944", "volume": "15", "author": "W Liu", "year": "2009", "unstructured": "Liu W, Laitinen S, Khan S, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med. 2009;15(5):559\u201365.", "journal-title": "Nat Med"}, {"issue": "6 Suppl", "key": "2_CR000272", "doi-asserted-by": "crossref", "first-page": "S12", "DOI": "10.1016/j.urology.2008.10.004", "volume": "72", "author": "AO Sartor", "year": "2008", "unstructured": "Sartor AO, Hricak H, Wheeler TM, et al. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology. 2008;72(6 Suppl):S12\u201324.", "journal-title": "Urology"}, {"issue": "8", "key": "2_CR000273", "doi-asserted-by": "crossref", "first-page": "1089", "DOI": "10.1111/j.1464-410X.2009.08904.x", "volume": "105", "author": "M Tsivian", "year": "2010", "unstructured": "Tsivian M, Kimura M, Sun L, Mouraviev V, Mayes JM, Polascik TJ. Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended. BJU Int. 2010;105(8):1089\u201392.", "journal-title": "BJU Int"}, {"issue": "6", "key": "2_CR000274", "doi-asserted-by": "crossref", "first-page": "2203", "DOI": "10.1016/j.juro.2008.01.114", "volume": "179", "author": "GS Yoon", "year": "2008", "unstructured": "Yoon GS, Wang W, Osunkoya AO, Lane Z, Partin AW, Epstein JI. Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol. 2008;179(6):2203\u20136 (discussion 2206).", "journal-title": "J Urol"}, {"issue": "1", "key": "2_CR000275", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1016/S0022-5347(05)66086-7", "volume": "166", "author": "M Noguchi", "year": "2001", "unstructured": "Noguchi M, Stamey TA, McNeal JE, Yemoto CM. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol. 2001;166(1):104\u20139 (discussion 109\u2013110).", "journal-title": "J Urol"}, {"issue": "2", "key": "2_CR000276", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.1148/radiol.2382041905", "volume": "238", "author": "L Wang", "year": "2006", "unstructured": "Wang L, Hricak H, Kattan MW, Chen HN, Scardino PT, Kuroiwa K. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology. 2006;238(2):597\u2013603.", "journal-title": "Radiology"}, {"issue": "1", "key": "2_CR000277", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1148/radiol.2421051254", "volume": "242", "author": "L Wang", "year": "2007", "unstructured": "Wang L, Hricak H, Kattan MW, et al. Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology. 2007;242(1):182\u20138.", "journal-title": "Radiology"}, {"issue": "5", "key": "2_CR000278", "doi-asserted-by": "crossref", "first-page": "1963", "DOI": "10.1016/j.juro.2010.06.136", "volume": "184", "author": "IG Jeong", "year": "2010", "unstructured": "Jeong IG, Kim JK, Cho KS, et al. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy. J Urol. 2010;184(5):1963\u20139.", "journal-title": "J Urol"}, {"issue": "4", "key": "2_CR000279", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.2214/ajr.162.4.8141009", "volume": "162", "author": "JH Ellis", "year": "1994", "unstructured": "Ellis JH, Tempany C, Sarin MS, Gatsonis C, Rifkin MD, McNeil BJ. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR Am J Roentgenol. 1994;162(4):865\u201372.", "journal-title": "AJR Am J Roentgenol"}, {"issue": "3", "key": "2_CR000280", "doi-asserted-by": "crossref", "first-page": "915", "DOI": "10.1016/S0022-5347(01)63770-4", "volume": "159", "author": "S Ikonen", "year": "1998", "unstructured": "Ikonen S, Karkkainen P, Kivisaari L, et al. Magnetic resonance imaging of clinically localized prostatic cancer. J Urol. 1998;159(3):915\u20139.", "journal-title": "J Urol"}, {"issue": "1", "key": "2_CR000281", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/j.urology.2004.02.036", "volume": "64", "author": "J Nakashima", "year": "2004", "unstructured": "Nakashima J, Tanimoto A, Imai Y, et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology. 2004; 64(1):101\u20135.", "journal-title": "Urology"}, {"issue": "5", "key": "2_CR000282", "doi-asserted-by": "crossref", "first-page": "1094", "DOI": "10.1016/j.urology.2009.04.102", "volume": "74", "author": "P Puech", "year": "2009", "unstructured": "Puech P, Potiron E, Lemaitre L, et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. Urology. 2009;74(5):1094\u20139.", "journal-title": "Urology"}, {"issue": "6", "key": "2_CR000283", "doi-asserted-by": "crossref", "first-page": "1163", "DOI": "10.1016/j.eururo.2006.06.025", "volume": "50", "author": "AP Kirkham", "year": "2006", "unstructured": "Kirkham AP, Emberton M, Allen C. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol. 2006;50(6):1163\u201374 (discussion 1175).", "journal-title": "Eur Urol"}, {"issue": "4", "key": "2_CR000284", "doi-asserted-by": "crossref", "first-page": "697", "DOI": "10.1016/j.mric.2008.07.005", "volume": "16", "author": "J Kurhanewicz", "year": "2008", "unstructured": "Kurhanewicz J, Vigneron DB. Advances in MR spectroscopy of the prostate. Magn Reson Imaging Clin N Am. 2008;16(4):697\u2013710 (ix\u2013x).", "journal-title": "Magn Reson Imaging Clin N Am"}, {"issue": "6", "key": "2_CR000285", "doi-asserted-by": "crossref", "first-page": "1471", "DOI": "10.2214/AJR.09.2527", "volume": "192", "author": "B Turkbey", "year": "2009", "unstructured": "Turkbey B, Albert PS, Kurdziel K, Choyke PL. Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol. 2009;192(6):1471\u201380.", "journal-title": "AJR Am J Roentgenol"}, {"issue": "9", "key": "2_CR000286", "doi-asserted-by": "crossref", "first-page": "886", "DOI": "10.1046/j.1464-410X.2002.02796.x", "volume": "89", "author": "SR Bott", "year": "2002", "unstructured": "Bott SR, Young MP, Kellett MJ, Parkinson MC. Anterior prostate cancer: is it more difficult to diagnose? BJU Int. 2002;89(9):886\u20139.", "journal-title": "BJU Int"}, {"issue": "2", "key": "2_CR000287", "doi-asserted-by": "crossref", "first-page": "470", "DOI": "10.1007/s00330-008-1153-0", "volume": "19", "author": "L Lemaitre", "year": "2009", "unstructured": "Lemaitre L, Puech P, Poncelet E, et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings. Eur Radiol. 2009; 19(2): 470\u201380.", "journal-title": "Eur Radiol"}, {"issue": "2 Suppl. 1", "key": "2_CR000288", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1016/S0090-4295(02)01683-7", "volume": "60", "author": "NE Hoffmann", "year": "2002", "unstructured": "Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40\u20139.", "journal-title": "Urology"}, {"issue": "4 Pt 1", "key": "2_CR000289", "doi-asserted-by": "crossref", "first-page": "1126", "DOI": "10.1097/01.ju.0000087860.52991.a8", "volume": "170", "author": "KR Han", "year": "2003", "unstructured": "Han KR, Cohen JK, Miller RJ, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003;170(4 Pt 1):1126\u201330.", "journal-title": "J Urol"}, {"issue": "2 Suppl 1", "key": "2_CR000290", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/S0090-4295(02)01678-3", "volume": "60", "author": "DK Bahn", "year": "2002", "unstructured": "Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60(2 Suppl 1):3\u201311.", "journal-title": "Urology"}, {"issue": "1", "key": "2_CR000291", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/S0090-4295(02)01643-6", "volume": "60", "author": "G Onik", "year": "2002", "unstructured": "Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R. Focal \u201cnerve-sparing\u201d cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60(1):109\u201314.", "journal-title": "Urology"}, {"issue": "9", "key": "2_CR000292", "doi-asserted-by": "crossref", "first-page": "688", "DOI": "10.1089/end.2006.20.688", "volume": "20", "author": "DK Bahn", "year": "2006", "unstructured": "Bahn DK, Silverman P, Lee Sr F, Badalament R, Bahn ED, Rewcastle JC. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006;20(9):688\u201392.", "journal-title": "J Endourol"}, {"issue": "6 Suppl", "key": "2_CR000293", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/j.urology.2007.07.036", "volume": "70", "author": "DS Ellis", "year": "2007", "unstructured": "Ellis DS, Manny Jr TB, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology. 2007;70(6 Suppl):9\u201315.", "journal-title": "Urology"}, {"issue": "6", "key": "2_CR000294", "doi-asserted-by": "crossref", "first-page": "1117", "DOI": "10.1016/j.urology.2007.02.047", "volume": "69", "author": "EH Lambert", "year": "2007", "unstructured": "Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007;69(6):1117\u201320.", "journal-title": "Urology"}, {"issue": "6 Suppl", "key": "2_CR000295", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.1016/j.urology.2007.06.001", "volume": "70", "author": "G Onik", "year": "2007", "unstructured": "Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J. \u201cMale lumpectomy\u201d: focal therapy for prostate cancer using cryoablation. Urology. 2007;70(6 Suppl):16\u201321.", "journal-title": "Urology"}, {"issue": "6", "key": "2_CR000296", "doi-asserted-by": "crossref", "first-page": "687", "DOI": "10.1159/000020219", "volume": "37", "author": "S Madersbacher", "year": "2000", "unstructured": "Madersbacher S, Schatzl G, Djavan B, Stulnig T, Marberger M. Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urol. 2000;37(6):687\u201394.", "journal-title": "Eur Urol"}, {"issue": "3", "key": "2_CR000297", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1089/end.1997.11.197", "volume": "11", "author": "K Nakamura", "year": "1997", "unstructured": "Nakamura K, Baba S, Saito S, Tachibana M, Murai M. High-intensity focused ultrasound energy for benign prostatic hyperplasia: clinical response at 6 months to treatment using Sonablate 200. J Endourol. 1997;11(3):197\u2013201.", "journal-title": "J Endourol"}, {"issue": "1", "key": "2_CR000298", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/S0929-8266(99)00010-5", "volume": "9", "author": "NT Sanghvi", "year": "1999", "unstructured": "Sanghvi NT, Foster RS, Bihrle R, et al. Noninvasive surgery of prostate tissue by high intensity focused ultrasound: an updated report. Eur J Ultrasound. 1999;9(1):19\u201329.", "journal-title": "Eur J Ultrasound"}, {"issue": "3", "key": "2_CR000299", "first-page": "799", "volume": "6", "author": "L Sullivan", "year": "1999", "unstructured": "Sullivan L, Casey RW, Pommerville PJ, Marich KW. Canadian experience with high intensity focused ultrasound for the treatment of BPH. Can J Urol. 1999;6(3):799\u2013805.", "journal-title": "Can J Urol"}, {"issue": "6", "key": "2_CR0002100", "doi-asserted-by": "crossref", "first-page": "1194", "DOI": "10.1016/j.eururo.2007.10.062", "volume": "53", "author": "A Blana", "year": "2008", "unstructured": "Blana A, Murat FJ, Walter B, et al. First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer. Eur Urol. 2008;53(6):1194\u2013201.", "journal-title": "Eur Urol"}, {"issue": "2", "key": "2_CR0002101", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1016/j.eururo.2006.04.012", "volume": "51", "author": "L Poissonnier", "year": "2007", "unstructured": "Poissonnier L, Chapelon JY, Rouviere O, et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol. 2007;51(2):381\u20137.", "journal-title": "Eur Urol"}, {"issue": "4", "key": "2_CR0002102", "doi-asserted-by": "crossref", "first-page": "559", "DOI": "10.1016/j.eururo.2010.06.037", "volume": "58", "author": "S Crouzet", "year": "2010", "unstructured": "Crouzet S, Rebillard X, Chevallier D, et al. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur Urol. 2010;58(4):559\u201366.", "journal-title": "Eur Urol"}, {"issue": "3", "key": "2_CR0002103", "doi-asserted-by": "crossref", "first-page": "192", "DOI": "10.1093/jjco/hym173", "volume": "38", "author": "S Muto", "year": "2008", "unstructured": "Muto S, Yoshii T, Saito K, Kamiyama Y, Ide H, Horie S. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol. 2008;38(3):192\u20139.", "journal-title": "Jpn J Clin Oncol"}, {"issue": "1", "key": "2_CR0002104", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1148/radiol.2441060398", "volume": "244", "author": "MA Haider", "year": "2007", "unstructured": "Haider MA, Davidson SR, Kale AV, et al. Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. Radiology. 2007;244(1):196\u2013204.", "journal-title": "Radiology"}, {"issue": "7", "key": "2_CR0002105", "doi-asserted-by": "crossref", "first-page": "672", "DOI": "10.1002/lsm.20375", "volume": "38", "author": "Z Huang", "year": "2006", "unstructured": "Huang Z, Haider MA, Kraft S, et al. Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland. Lasers Surg Med. 2006;38(7):672\u201381.", "journal-title": "Lasers Surg Med"}, {"issue": "5", "key": "2_CR0002106", "doi-asserted-by": "crossref", "first-page": "1974", "DOI": "10.1016/j.juro.2007.07.036", "volume": "178", "author": "J Trachtenberg", "year": "2007", "unstructured": "Trachtenberg J, Bogaards A, Weersink RA, et al. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. J Urol. 2007;178(5):1974\u20139 (discussion 1979).", "journal-title": "J Urol"}, {"issue": "5", "key": "2_CR0002107", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1111/j.1464-410X.2008.07753.x", "volume": "102", "author": "J Trachtenberg", "year": "2008", "unstructured": "Trachtenberg J, Weersink RA, Davidson SR, et al. Vascular-targeted photodynamic therapy (pado\u00adporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU Int. 2008;102(5):556\u201362.", "journal-title": "BJU Int"}, {"issue": "5", "key": "2_CR0002108", "doi-asserted-by": "crossref", "first-page": "775", "DOI": "10.1089/end.2009.0596", "volume": "24", "author": "J Rosette de la", "year": "2010", "unstructured": "de la Rosette J, Ahmed H, Barentsz J, et al. Focal therapy in prostate cancer-report from a consensus panel. J Endourol. 2010;24(5):775\u201380.", "journal-title": "J Endourol"}, {"issue": "Pt 1", "key": "2_CR0002109", "first-page": "425", "volume": "10", "author": "GS Fischer", "year": "2007", "unstructured": "Fischer GS, DiMaio SP, Iordachita II, Fichtinger G. Robotic assistant for transperineal prostate interventions in 3 T closed MRI. Med Image Comput Comput Assist Interv. 2007;10(Pt 1):425\u201333.", "journal-title": "Med Image Comput Comput Assist Interv"}, {"issue": "1", "key": "2_CR0002110", "first-page": "7", "volume": "11", "author": "PC Mozer", "year": "2009", "unstructured": "Mozer PC, Partin AW, Stoianovici D. Robotic image-guided needle interventions of the prostate. Rev Urol. 2009;11(1):7\u201315.", "journal-title": "Rev Urol"}, {"issue": "1", "key": "2_CR0002111", "first-page": "e1", "volume": "60", "author": "G Ploussard", "year": "2010", "unstructured": "Ploussard G, Durand X, Xylinas E, et al. Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance. Eur Urol. 2010; 60(1):e1\u20138.", "journal-title": "Eur Urol"}, {"issue": "1", "key": "2_CR0002112", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1002/(SICI)1097-0045(19990401)39:1<41::AID-PROS7>3.0.CO;2-5", "volume": "39", "author": "HP Beerlage", "year": "1999", "unstructured": "Beerlage HP, van Leenders GJ, Oosterhof GO, et al. High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study. Prostate. 1999;39(1):41\u20136.", "journal-title": "Prostate"}, {"issue": "6 Suppl", "key": "2_CR0002113", "doi-asserted-by": "crossref", "first-page": "S1", "DOI": "10.1016/j.urology.2008.07.072", "volume": "72", "author": "PT Scardino", "year": "2008", "unstructured": "Scardino PT, Abenhaim LL. Focal therapy for prostate cancer: analysis by an international panel. Urology. 2008;72(6 Suppl):S1\u20132.", "journal-title": "Urology"}, {"issue": "4", "key": "2_CR0002114", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1200/JCO.2010.32.5308", "volume": "29", "author": "PR Carroll", "year": "2011", "unstructured": "Carroll PR, Whitson JM, Cooperberg MR. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes? J Clin Oncol. 2011;29(4):345\u20137.", "journal-title": "J Clin Oncol"}, {"key": "2_CR0002115", "doi-asserted-by": "crossref", "first-page": "839", "DOI": "10.1016/j.urology.2007.09.001", "volume": "70", "author": "F Dong", "year": "2007", "unstructured": "Dong F, Reuther AM, Maqi-Galluzzi C, et al. Pathologic stage migration has slowed in the late PSA era. Urology. 2007;70:839\u201342.", "journal-title": "Urology"}], "container-title": ["Imaging and Focal Therapy of Early Prostate Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-62703-182-0_2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T11:11:10Z", "timestamp": 1557400270000}, "score": 36.47124, "issued": {"date-parts": [[2012, 11, 3]]}, "ISBN": ["9781627031813", "9781627031820"], "references-count": 115, "URL": "http://dx.doi.org/10.1007/978-1-62703-182-0_2", "relation": {"cites": []}}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}